Laboratory Medicine Program

Lung Adenocarcinoma (circulating tumour DNA)
(ctDNA, liquid biopsy)

Clinical Decription:
Testing of circulating tumour DNA (ctDNA) enables detection of clinically relevant mutations without invasive tissue biopsy. Eligibility Criteria: Patients with metastatic NSCLC (confirmed by biopsy) where molecular biomarker testing on tissue failed or tissue was insufficient for testing (would otherwise require another biopsy/repeat NGS) OR Patients with suspected advanced or metastatic lung cancer who are unsuitable for or unable to get a tissue biopsy OR Patients with a high-risk for deterioration who cannot wait for NGS tissue results.

Method: Next-Generation Sequencing (NGS)

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: Peripheral Blood
Collected In: cell-free DNA BCT STRECK tubes (tan/mottled tan cap)
Volume: 27 mL mL (minimum: 27 mL mL)

Shipping: room temperature or 4C

Special Instructions: See requisitions for the full list of available testing and special instructions

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227